Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700711 · ClinicalTrials.gov registry record · Phase 1
Methylphenidate-Duloxetine Combinations for Cocaine Dependence
A Phase 1 study, sponsored by University of Kentucky.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT02700711: Completed Phase 1 study, sponsored by University of Kentucky.
NCT02700711 is a Phase 1 study that has completed, run by University of Kentucky. The registered enrollment target is 13 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02700711, a Phase 1 study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will determine the influence of methylphenidate (e.g., Ritalin®) and duloxetine (Cymbalta®), alone and in combination, on the cocaine use as measured by self-report and urine drug screens.
Primary Outcome
Cocaine use will be assessed using qualitative urine drug screens over a six week period.
Interventions
- DRUG Placebo
- DRUG Duloxetine
- DRUG Methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-06 |
| Phase | Phase 1 |
What the finished NCT02700711 record still lists
NCT02700711 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02700711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02700711 about?
NCT02700711 is a clinical study titled "Methylphenidate-Duloxetine Combinations for Cocaine Dependence". This study will determine the influence of methylphenidate (e.g., Ritalin®) and duloxetine (Cymbalta®), alone and in combination, on the cocaine use as measured by self-report and urine drug screens.
What is the current status of trial NCT02700711?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2016-02. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02700711?
The interventions under investigation include: Placebo (DRUG), Duloxetine (DRUG), Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT02700711?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02700711's enrollment target sits among peer trials
13 1847th of 2000 higher than 149 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia